Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
出版年份 2019 全文链接
标题
Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
作者
关键词
-
出版物
Cells
Volume 8, Issue 2, Pages 84
出版商
MDPI AG
发表日期
2019-01-25
DOI
10.3390/cells8020084
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabolomic Profiles for Primary Progressive Multiple Sclerosis Stratification and Disease Course Monitoring
- (2018) Daniel Stoessel et al. Frontiers in Human Neuroscience
- Dysregulation of methionine metabolism in multiple sclerosis
- (2018) N.K. Singhal et al. NEUROCHEMISTRY INTERNATIONAL
- DNA methylation as a mediator of HLA-DRB1*15:01 and a protective variant in multiple sclerosis
- (2018) Lara Kular et al. Nature Communications
- Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
- (2018) Smitha Krishnan et al. Cell Reports
- Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
- (2018) Stephanie Herman et al. Theranostics
- Altered tryptophan metabolism is associated with pediatric multiple sclerosis risk and course
- (2018) Bardia Nourbakhsh et al. Annals of Clinical and Translational Neurology
- Dimethyl fumarate treatment induces lipid metabolism alterations that are linked to immunological changes
- (2018) Pavan Bhargava et al. Annals of Clinical and Translational Neurology
- Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis
- (2017) Simone Poddighe et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions
- (2017) Stephanie Herman et al. Metabolomics
- Serotonin: A mediator of the gut–brain axis in multiple sclerosis
- (2017) Tsveta S Malinova et al. Multiple Sclerosis Journal
- Mechanism of action of three newly registered drugs for multiple sclerosis treatment
- (2017) Kaja Kasarełło et al. Pharmacological Reports
- Epigenetic research in multiple sclerosis: progress, challenges, and opportunities
- (2017) Galina Y. Zheleznyakova et al. PHYSIOLOGICAL GENOMICS
- Metabolomic profiling of CSF in multiple sclerosis and neuromyelitis optica spectrum disorder by nuclear magnetic resonance
- (2017) Hyun-Hwi Kim et al. PLoS One
- Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health
- (2017) Igor Cervenka et al. SCIENCE
- Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression
- (2017) Chai K. Lim et al. Scientific Reports
- Serotonin: A mediator of the gut–brain axis in multiple sclerosis
- (2017) Tsveta S Malinova et al. Multiple Sclerosis Journal
- Metabolomics reveals distinct, antibody-independent, molecular signatures of MS, AQP4-antibody and MOG-antibody disease
- (2017) Maciej Jurynczyk et al. Acta Neuropathologica Communications
- Enzymology of Pyrimidine Metabolism and Neurodegeneration
- (2016) Silvia Vincenzetti et al. CURRENT MEDICINAL CHEMISTRY
- THE MS-SMART TRIAL IN SECONDARY PROGRESSIVE MS – CURRENT UPDATE
- (2016) Jeremy Chataway et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Metabolomics in multiple sclerosis
- (2016) Pavan Bhargava et al. Multiple Sclerosis Journal
- Metabolic Biomarkers and Neurodegeneration: A Pathway Enrichment Analysis of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
- (2016) Medi Kori et al. OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY
- Disease modifying therapies for relapsing multiple sclerosis
- (2016) Dean M Wingerchuk et al. BMJ-British Medical Journal
- Disease modifying therapies for relapsing multiple sclerosis
- (2016) Dean M Wingerchuk et al. BMJ-British Medical Journal
- Metabolomics in multiple sclerosis
- (2016) Pavan Bhargava et al. Multiple Sclerosis Journal
- The Effect of Age Correction on Multivariate Classification in Alzheimer’s Disease, with a Focus on the Characteristics of Incorrectly and Correctly Classified Subjects
- (2015) Farshad Falahati et al. BRAIN TOPOGRAPHY
- Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System
- (2015) Cecilia Rajda et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Changes in Methionine Metabolism and Histone H3 Trimethylation Are Linked to Mitochondrial Defects in Multiple Sclerosis
- (2015) N. K. Singhal et al. JOURNAL OF NEUROSCIENCE
- Analysis of the Human Adult Urinary Metabolome Variations with Age, Body Mass Index, and Gender by Implementing a Comprehensive Workflow for Univariate and OPLS Statistical Analyses
- (2015) Etienne A. Thévenot et al. JOURNAL OF PROTEOME RESEARCH
- Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives
- (2015) Daniel Ontaneda et al. LANCET NEUROLOGY
- Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
- (2015) EL MacMillan et al. Multiple Sclerosis Journal
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- MetaboAnalyst 3.0—making metabolomics more meaningful
- (2015) Jianguo Xia et al. NUCLEIC ACIDS RESEARCH
- Progressive multiple sclerosis exhibits decreasing glutamate and glutamine over two years
- (2015) EL MacMillan et al. Multiple Sclerosis Journal
- Pathway Analysis: State of the Art
- (2015) Miguel A. García-Campos et al. Frontiers in Physiology
- Immunomodulatory Effects Mediated by Serotonin
- (2015) Rodrigo Arreola et al. Journal of Immunology Research
- Drug Repurposing: A Systematic Approach to Evaluate Candidate Oral Neuroprotective Interventions for Secondary Progressive Multiple Sclerosis
- (2015) Hanna M. Vesterinen et al. PLoS One
- Assessing tissue damage in multiple sclerosis: a biomarker approach
- (2014) J. Burman et al. ACTA NEUROLOGICA SCANDINAVICA
- Teriflunomide and Its Mechanism of Action in Multiple Sclerosis
- (2014) Amit Bar-Or et al. DRUGS
- Altered serotonin transporter availability in patients with multiple sclerosis
- (2014) Swen Hesse et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Metabolite identification: are you sure? And how do your peers gauge your confidence?
- (2014) Darren J. Creek et al. Metabolomics
- Metabolomic profiling in multiple sclerosis: insights into biomarkers and pathogenesis
- (2014) SN Reinke et al. Multiple Sclerosis Journal
- Metabolomic markers reveal novel pathways of ageing and early development in human populations
- (2013) Cristina Menni et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- An Automated Pipeline for High-Throughput Label-Free Quantitative Proteomics
- (2013) Hendrik Weisser et al. JOURNAL OF PROTEOME RESEARCH
- Automated Label-free Quantification of Metabolites from Liquid Chromatography–Mass Spectrometry Data
- (2013) Erhan Kenar et al. MOLECULAR & CELLULAR PROTEOMICS
- Epigenome-wide differences in pathology-free regions of multiple sclerosis–affected brains
- (2013) Jimmy L Huynh et al. NATURE NEUROSCIENCE
- Tryptophan metabolism: entering the field of aging and age-related pathologies
- (2013) Annemieke T. van der Goot et al. TRENDS IN MOLECULAR MEDICINE
- A cross-platform toolkit for mass spectrometry and proteomics
- (2012) Matthew C Chambers et al. NATURE BIOTECHNOLOGY
- Kynurenines in the CNS: recent advances and new questions
- (2012) László Vécsei et al. NATURE REVIEWS DRUG DISCOVERY
- Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
- (2011) Chris H. Polman et al. ANNALS OF NEUROLOGY
- pROC: an open-source package for R and S+ to analyze and compare ROC curves
- (2011) Xavier Robin et al. BMC BIOINFORMATICS
- Metabolic Profiling in Multiple Sclerosis and Other Disorders by Quantitative Analysis of Cerebrospinal Fluid Using Nuclear Magnetic Resonance Spectroscopy
- (2011) N. W. Lutz et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking
- (2009) C. E. Teunissen et al. NEUROLOGY
- NMR-based metabolomic analysis of cerebrospinal fluid and serum in neurological diseases - a diagnostic tool?
- (2009) Alexandra J. Sinclair et al. NMR IN BIOMEDICINE
- Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis
- (2008) Manolis Markianos et al. JOURNAL OF NEUROCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started